[1]周晓燕姚旺石小鹏杨彦平王琳程功梅王超郗莹张艳青王聪聪陈晓华贾婉婉代玉洁郭文娟.建立高危新生儿肠外营养液药学监护新模式[J].中国卫生质量管理,2018,25(01):84-90.[doi:10.13912/j.cnki.chqm.2018.25.1.28]

点击复制

建立高危新生儿肠外营养液药学监护新模式

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R] 卷: 第25卷期数: 2018年01期页码: 84-90 栏目: QC小组平台出版日期: 2018-01-28

作者:: 周晓燕姚旺石小鹏杨彦平王琳程功梅王超郗莹张艳青王聪聪陈晓华贾婉婉代玉洁郭文娟; 空军军医大学西京医院

关键词:: 高危; 新生儿; 肠外营养液; 药学监护

Keywords:: High Risk; Newborn; Total Parenteral Nutrition; Pharmaceutical Care

DOI:: 10.13912/j.cnki.chqm.2018.25.1.28

摘要:: 针对高危新生儿肠外营养液药学监护开展品管圈活动。国内目前尚无高危新生儿肠外营养液完善的质量监控体系，结合工作实际发掘了5大攻坚点，包括成立成品输液质量抽检小组，研发PIVAS伴侣软件并建立成品钾离子浓度检测方法，增加资金投入，合理用药建议与科普知识传递信息化并建立营养风险筛查与评估量表，创建团队协作药学监护模式等。针对5大攻坚点进行最适方策追究，从调配前干预、调配中监管、调配后追踪3方面，构建了高危新生儿肠外营养液药学监护模式，并取得了良好的临床应用效果。

Abstract:: The quality control activity was carried out for high-risk neonates on parenteral nutrition pharmaceutical care. There had no perfect quality control system on parenteral nutrition pharmaceutical care for high risk newborns in China, and five crucial points were discovered in practice, including establishment of a quality spot check team on finished infusion, development of PIVAS partner software and establishment of the product potassium ion concentration detection method, increasing funding investment, rational drug use advice and scientific knowledge propagation, establishment of a nutritional risk screening and evaluation scale, establishment of a teamwork pharmaceutical care mode. The optimal strategies were analyzed based on the five crucial points, and the parenteral nutrition pharmaceutical care new mode for high-risk newborns was established from three aspects of pre-mixing intervention, interim supervision and post track, which achieved good clinical effect.

参考文献/References:

［1］艾义晓.高危新生儿出院后的随访［J］.中国医药指南,2014,12(7):92-93.

相似文献/References:

[1]曾跃萍吕亚奇田剑张欣王丽刘颖陈燕华宋菲刘帅.新生儿DRGs分组PU11组中影响总费用的因素分析[J].中国卫生质量管理,2020,27(05):47.
　ZENG Yueping,LV Yaqi,TIAN Jian,et al.Analysis on Influencing Factors for Total Expense of Diagnosis Related Groups (PU11) in Neonates[J].Chinese Health Quality Management,2020,27(01):47.
[2]郑美徐步龙李浩.1例新生儿葡萄糖注射液浓度错误的解析与改进[J].中国卫生质量管理,2021,28(04):52.[doi:10.13912/j.cnki.chqm.2021.28.4.15 ]
　ZHENG Mei,XU Bulong,LI Hao.Analysis and Improvement of a Concentration Error of Neonatal Glucose Injection[J].Chinese Health Quality Management,2021,28(01):52.[doi:10.13912/j.cnki.chqm.2021.28.4.15 ]
[3]付婷辉冷京倍陈吟仇叶龙董爱然侯东敏郭默宁.新生儿出生体重与入院体重对DRG分组影响分析[J].中国卫生质量管理,2023,30(05):55.[doi:10.13912/j.cnki.chqm.2023.30.5.12 ]
　FU Tinghui,LENG Jingbei,CHEN Yin.Effect of Neonatal Birth Weight and Admission Weight on DRG Grouping[J].Chinese Health Quality Management,2023,30(01):55.[doi:10.13912/j.cnki.chqm.2023.30.5.12 ]
[4]黄书琳林晓忆卢琪琪栗美娜.协同创新视角下新生儿出生“一件事”政务服务改革研究[J].中国卫生质量管理,2026,33(2):53.[doi:10.13912/j.cnki.chqm.2026.33.2.11]
　HUANG Shulin,LIN Xiaoyi,LU Qiqi.Research on the Government Service Reform of "One-Stop Service" for Newborn Birth from the Perspective of Collaborative Innovation[J].Chinese Health Quality Management,2026,33(01):53.[doi:10.13912/j.cnki.chqm.2026.33.2.11]

更新日期/Last Update: 2018-01-28